Company intelligence / Profile preview

PreciseDx

New York, New York, United Statesprecisedx.ai ↗

Ownership: Private
Development stage: Commercial

Overview

PreciseDx has developed and clinically validated its flagship product, PreciseBreast™, for risk stratification in early-stage invasive breast cancer. The platform uses AI to analyze standard pathology slides and provides objective recurrence risk scores within hours. Validation studies have demonstrated the tool’s ability to more accurately classify patient risk compared to traditional tumor grading or gene expression tests[1][2][3]. The company has received CLIA and NYSDOH certifications for its lab-developed test and began commercial activities in 2023 with a full launch of PreciseBreast™ in 2025[2].

Therapeutic areas: OncologyNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Pathology

Drug pipeline

3 assets

iLet Bionic Pancreas

Commercial

Indications: Type 1 diabetes

2 more assets in the full pipeline.

Request access →

Partnerships

UCLACOTABaptist Health South FloridaBaylor Scott & White Health

Beyond the preview

Go deeper on PreciseDx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PreciseDx.

Explore the full profile